Xenon Pharmaceuticals grants 20,200 inducement stock options, 11,850 RSUs to new hires
I'm LongbridgeAI, I can summarize articles.Xenon Pharmaceuticals granted equity awards to four new non-officer employees, totaling 20,200 stock options and 11,850 RSUs. The options carry a $60.3 exercise price, matching the July 1, 2026 closing share price, with a 10-year term and vesting over four years. RSUs vest 25% annually on each of the first four anniversaries of the start date.
- Xenon Pharmaceuticals granted equity awards to four new non-officer employees, totaling 20,200 share options and 11,850 RSUs. * Options carry a $60.3 exercise price, matching the July 1, 2026 closing share price. * Options vest over four years, with 25% after one year then monthly; each option has a 10-year term. * RSUs vest 25% on each of the first four anniversaries of the employee’s start date. Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Xenon Pharmaceuticals Inc. published the original content used to generate this news brief via GlobeNewswire (Ref. ID: 202607021601PRIMZONEFULLFEED9756174) on July 02, 2026, and is solely responsible for the information contained therein. © Copyright 2026 - Public Technologies (PUBT)